TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $309 | -1.6% | 20 | 0.0% | 0.00% | – |
| Q2 2023 | $314 | -4.8% | 20 | 0.0% | 0.00% | – |
| Q1 2023 | $330 | +5.8% | 20 | 0.0% | 0.00% | – |
| Q4 2022 | $312 | – | 20 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 20 | -89.5% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 190 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -99.4% | 190 | -99.3% | 0.00% | -100.0% |
| Q2 2020 | $486,000 | +15.2% | 27,113 | -2.6% | 0.04% | 0.0% |
| Q1 2020 | $422,000 | +2.7% | 27,825 | +33.7% | 0.04% | +11.4% |
| Q4 2019 | $411,000 | +13.5% | 20,808 | -1.0% | 0.04% | +6.1% |
| Q3 2019 | $362,000 | +160.4% | 21,024 | +167.5% | 0.03% | +120.0% |
| Q2 2019 | $139,000 | -12.6% | 7,860 | +1.0% | 0.02% | -21.1% |
| Q1 2019 | $159,000 | – | 7,783 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |